K110449 is an FDA 510(k) clearance for the ENDOBON XENOGRAFT GRANULES. This device is classified as a Bone Grafting Material, Synthetic (Class II - Special Controls, product code LYC).
Submitted by Biomet 3i (Palm Beach Gardens, US). The FDA issued a Cleared decision on May 13, 2011, 86 days after receiving the submission on February 16, 2011.
This device falls under the Dental FDA review panel. Regulated under 21 CFR 872.3930. A Synthetic Bone Grafting Material Is Synthetically-derived Device, Such As Hydroxylapatite, Intended To Fill, Augment, Or Reconstruct Periodontal And Or Bony Defects Of The Upper Or Lower Jaw..